Baptisia 1:2 500ml

$285.95

Description

MediHerb Baptisia 1:2 500ml: Natural Support for Respiratory and Oral Health

MediHerb’s Baptisia 1:2 500ml is derived from the root of Baptisia tinctoria, a traditional Western herbal remedy known for relieving upper respiratory tract infections, mouth inflammations, and sore gums. It is also used to support mild feverish conditions.

Discover how natural remedies can support respiratory health in our article Asthma Relief Through Naturopathy: Diet, Herbs, and Lifestyle Tips. Learn how Baptisia and other herbs play a role in enhancing respiratory wellness.

Key Benefits

Baptisia extract provides targeted support for:

  • Upper Respiratory Relief: Helps alleviate symptoms of upper respiratory tract infections, offering relief for sore throats, enlarged lymph glands, and related discomforts.
  • Oral Health: Traditionally used to soothe inflammations of the mouth, mild mouth ulcers, and sore gums.
  • Mild Fever Support: Supports the body during mild feverish conditions, aiding recovery and promoting overall well-being.
Ideal For

This product is ideal for individuals seeking:

  • Relief from upper respiratory tract infections and sore throats.
  • Support for oral health, including mild ulcers and sore gums.
  • Herbal assistance in managing mild feverish conditions.
Botanical Information
  • Botanical Name: Baptisia tinctoria
  • Plant Part Used: Root
  • Ethanol Content: 60%, ensuring effective extraction of active compounds.
Dose

Recommended dosage:

  • Adults: Take 8-20 mL per week, not exceeding 3 mL per day.
  • It is vital to accurately measure the dose to minimize the chance of adverse effects or toxicity.
Allergen Information

No added Gluten or Dairy. This product is vegan-friendly, suitable for a wide range of dietary preferences.

Warnings, Cautions, and Contraindications

Important safety information:

  • Do not exceed 3 mL per day due to the narrow dosage range and potential for adverse effects.
  • Professional supervision is recommended during pregnancy and lactation.
  • Discontinue use 7 days prior to scheduled general anesthesia.